Dr Chris Milton has continued his research into the effectiveness of specific drugs. These drugs could be a potential therapeutic for patients with DSRCT and rhabdomyosarcoma. Chris has written up his initial findings and submitted this as a paper to be considered for publication in an internationally acclaimed journal.